Frontiers in Pharmacology (Oct 2020)

Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients

  • Fuxun Yang,
  • Ruiming Yue,
  • Xiaoxiu Luo,
  • Rongan Liu,
  • Xiaobo Huang

DOI
https://doi.org/10.3389/fphar.2020.543718
Journal volume & issue
Vol. 11

Abstract

Read online

Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.

Keywords